Clinical trial Recruiting at 1 site Interventional Ages 40 to 70

Mushroom-shaped femoral bone graft plus locking plate versus locking plate alone for 3- and 4-part proximal humerus fractures.

Official title: Hip-allograft In Proximal Humerus Fractures Versus Plate Implantation Alone: a Randomized Controlled Trial

Run by Tergooi Medical Center · NCT07538700 · Data updated 2026-11-12

This trial will see if adding a mushroom-shaped femoral bone graft to locking-plate fixation helps adults aged 40–70 with recent 3- or 4-part proximal humerus fractures regain better shoulder function than plate fixation alone.

More Proximal Humeral Fracture trials

Quick facts

Study typeInterventional
Ages40 Years to 70 Years
SexAll
Enrollment56 (estimated)
SponsorTergooi Medical Center
Academic / other
Locations1 site (Hilversum)
StatusRecruiting
StartedMay 21, 2025
Main results expectedMay 2029
Study endsMay 2029
Registry record updatedApril 20, 2026
Trial IDNCT07538700 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are Dutch-speaking adults aged 40–70 with an acute (<3 weeks) displaced 3- or 4-part proximal humerus fracture who can give informed consent and complete follow-up.

Probably not a fit

Patients with head-split or pathological fractures, prior surgery or prior fracture of the same shoulder, active infection, dementia or other cognitive impairment, seizures, collagen diseases, or other conditions limiting shoulder mobility are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center randomized trial at Tergooi Medical Center compares locking-plate fixation with and without mushroom-shaped femoral allograft augmentation for displaced 3- and 4-part proximal humerus fractures. Eligible patients are adults aged 40–70 presenting within three weeks of injury and able to consent and communicate in Dutch. The primary outcome is the Constant-Murley Score at 24 months, with secondary outcomes including Oxford Shoulder Score, Subjective Shoulder Value, pain scores, quality of life (EQ-5D- L), radiographic measures, and complication rates. Participants are randomized to receive either LCP fixation plus allograft or LCP fixation alone and followed for clinical and radiological outcomes up to 24 months.

Why it matters

Potential benefit: If successful, this approach could improve long-term shoulder function and reduce fixation failures after complex proximal humerus fractures.

How similar studies have gone: Small series and case reports have reported promising results for femoral allograft augmentation, but randomized controlled evidence is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients between 40 and 70 years
* Presenting with acute (\< 3 weeks) 3- or 4-part PHF (NEER classification) Be able to understand and communicate in Dutch; Patient must be competent to make decisions; Patient is willing and able to complete scheduled study procedures Provide written IC.

Exclusion Criteria:

* Head-split fractures;
* Pathological fractures due to malignancy or metastases;
* Individuals diagnosed with dementia or residing in institutional care or other cognitive impairment;
* Terminal illness; Patients with convulsive disorders, collagen diseases, and any other condition that might affect the mobility of the shoulder joint; Active joint or systemic infection; History of prior surgery on the same shoulder; Previous fracture in the same shoulder; Psychiatric illness that precludes informed consent.

Where it's running

  • Tergooi Medical Center
    Hilversum, Netherlands
    Recruiting

Study contacts

  • Principal investigator: Laura M. Kok, MD, PhD — Tergooi Medical Center
  • Study coordinator: Dominique C Baas, PhD
  • Email: dbaas@tergooi.nl
  • Phone: +31887535153

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.